Skip to main content
GWGovwatch
CongressBillsCommitteesPresidentMoneyPulseMisconductElectionsMap
Donate

Weekly accountability digest

One email a week with new votes, moving bills, and misconduct updates. No spam.

GW

Govwatch. Public data about Congress, in one place, in plain English.

Built with public data. Not affiliated with the U.S. government.

Explore

  • Officials
  • Legislation
  • Committees
  • Congress Pulse
  • Trending Topics
  • Bipartisan Leaderboard
  • Weekly Digest
  • Misconduct
  • Predictions

Learn

  • How Congress Works
  • How a Bill Becomes Law
  • Campaign Finance 101
  • Glossary

Tools

  • My Representatives
  • Compare Members
  • Bill Watchlist
  • Search
  • District Map
  • Follow the Money
  • Watch Live

Site

  • About
  • Contact
  • Corrections
  • Privacy Policy
  • Terms of Service

Data Sources

Congress.gov API v3
Bills, members, votes
GovInfo API
Floor speeches, reports, bill text
Federal Election Commission (FEC)
Campaign finance
VoteView (UCLA)
Ideology scores (DW-NOMINATE)
GovTrack.us
Misconduct data (CC0)
U.S. Census Bureau
District demographics
Support This Project

This site is free. Donations help cover hosting, API fees, and keeping the data fresh.

All data is sourced from official government APIs and public records. This site is for informational purposes only.

© 2026 Govwatch

HR6509Referred to Committee

SAFE Drugs Act of 2025

Share:
Introduced
In Committee
3
Passed One Chamber
4
Passed Both
5
Signed into Law
119th
Congress
2025-12-09
Introduced
16
Cosponsors
HR
ⓘ
Type

Sponsor

Rudy Yakym III
Rudy Yakym III
Republican · IN · Representative
Votes with party: 99.1% (554 recorded votes)

Full profile: /officials/Y000067

Source: Congress.gov · FEC

Cosponsors (16)

Members who have signed on to support this bill since introduction. Source: Congress.gov.

  • André Carson (D-IN-7)Original· 2025-12-09
  • Eugene Simon Vindman (D-VA-7)· 2026-01-30
  • John J. McGuire III (R-VA-5)· 2026-01-30
  • Deborah K. Ross (D-NC-2)· 2026-02-11
  • Nathaniel Moran (R-TX-1)· 2026-02-11
  • Carol D. Miller (R-WV-1)· 2026-03-03
  • Claudia Tenney (R-NY-24)· 2026-03-03
  • Addison P. McDowell (R-NC-6)· 2026-03-05
  • Aaron Bean (R-FL-4)· 2026-03-17
  • Mike Kelly (R-PA-16)· 2026-03-18
  • James R. Baird (R-IN-4)· 2026-04-13
  • Erin Houchin (R-IN-9)· 2026-04-15
  • Jefferson Shreve (R-IN-6)· 2026-05-12
  • Vince Fong (R-CA-20)· 2026-05-12

Latest Action

The most recent step in the bill's legislative path. Committee Activity below shows referrals and reports; the full action-by-action history including floor proceedings lives at Congress.gov →

Referred to the House Committee on Energy and Commerce.

2025-12-09

Source: Congress.gov

Committee Activity

Currently in

  • House Committee on Energy and CommerceReferred To · 2025-12-09

Previously

  • Energy and Commerce CommitteeReferred To · 2025-12-09

Plain-English Summary

The bill would establish new safety standards and oversight procedures for pharmaceutical drugs, likely including requirements for manufacturers to report adverse effects more quickly and for the FDA to have stronger authority to monitor drug safety after approval. It would affect drug companies, patients who take medications, and healthcare providers by potentially requiring more rigorous testing and transparency about drug risks. The goal appears to be preventing unsafe drugs from reaching patients and ensuring faster removal of dangerous medications from the market.

AI-assisted summary generated from the official bill metadata (title, subjects, actions) sourced from Congress.gov. Cached and reviewed. Always verify against the official text linked below.

Subjects

Health
Full bill text is not yet cached locally.
Open text viewRead on Congress.gov

Related legislation

Bills by the same sponsor or covering overlapping subjects.

  • HR8953Preserving Community Food Assistance Act of 2026
    Referred to Committee · 2026-05-21
  • HR7655Support for Expectant and Parenting Foster Youth Act
    Referred to Committee · 2026-05-11
  • HR8672To amend the Internal Revenue Code of 1986 to allow a deduction for loan interest payments made with respect to certain vehicles.
    Referred to Committee · 2026-05-07
  • HR8319KIDNEY Remote Monitoring Act
    Referred to Committee · 2026-04-16